Triamine

Spermidine (Triamine): A Comprehensive Reference

1. Identity and Chemical Classification

Spermidine is the principal naturally occurring dietary triamine studied in human nutrition and supplementation science. In organic chemistry, a triamine is defined as any compound having three amino groups. Spermidine exemplifies this class: spermidine (N-(3-aminopropyl)-1,4-butane diamine), spermine (N,N-bis(3-aminopropyl)-1,4-butane diamine), and putrescine (1,4-butane diamine) have a low molecular weight and are characterized by having two or more amino groups.

Spermidine is a polyamine compound (C₇H₁₉N₃) originally isolated from semen and also found in ribosomes and living tissues, and has various metabolic functions in organisms. Its three amine groups — two primary and one secondary — give it the triamine classification, distinguishing it from the diamine putrescine and the tetraamine spermine.

As a dietary supplement, spermidine is commercially prepared in several forms:

• Wheat germ extract: A concentrated plant-derived powder standardized to a defined spermidine content, used in most early human trials.
• High-purity spermidine trihydrochloride (hpSPD): This represents the first human study of a novel, high-purity spermidine-trihydrochloride supplement, and the study represents the first investigation into the safety of this novel form in humans.
• Capsules and powders derived from fermented or plant sources, including natto, soybean, and aged cheese extracts.

2. Natural Sources and Distribution

Spermidine is a natural polyamine present in all living organisms that is critically involved in the maintenance of cellular homeostasis. It is found across the kingdoms of life — in bacteria, fungi, plants, and animals — and is an obligate component of actively dividing cells.

Good dietary sources of spermidine are aged cheese, mushrooms, soy products, legumes, corn, and whole grains. Spermidine is plentiful in a Mediterranean diet. Among grain sources, the endosperm contains most of the spermidine; one of the best-known grain dietary sources is wheat germ, containing as much as 243 mg/kg.

Spermidine is found in abundance in certain foods such as wheat germ, natto, soybeans, aged cheese, and mushrooms.

Spermidine and spermine are naturally present in food whereas putrescine could also have a microbial origin. The main polyamine in plant-based products is spermidine, whereas spermine content is generally higher in animal-derived foods.

Higher concentrations of polyamines are found in fermented food products such as sauerkraut, some sausages, and cheeses. In plants, exposure to salt or osmotic stress appeared to enhance polyamine biosynthesis, and thereby the contents of polyamines increased.

In the human body, the pool of available spermidine comes from three converging sources: endogenous or de novo biosynthesis, intestinal microorganisms, and exogenous food intake. Intracellular polyamine pools are tightly regulated by a complex regulatory mechanism involving de novo biosynthesis, catabolism, and transport across the plasma membrane. In mammals, both the production of polyamines and their uptake from the extracellular space are controlled by a set of proteins named antizymes and antizyme inhibitors.

3. Historical Discovery and Early Research

In 1678, Antoni van Leeuwenhoek discovered the presence of crystals in human semen, which 200 years later (1888) were named spermine by A. Ladenburg and J. Abel. The chemical structure of spermine and spermidine was determined in 1924.

The identification of spermidine as a triamine compound of biological importance catalyzed decades of biochemical investigation into polyamine metabolism. Polyamines (putrescine, spermine, and spermidine) are aliphatic amines that are reported to be essential components of all living cells. Because of their roles in cellular growth, normal function, and proliferation, these biologically active compounds have been of main interest among the group of biogenic amines.

The modern era of spermidine supplementation research was inaugurated in 2009 with the landmark publication in Nature Cell Biology demonstrating that induction of autophagy by spermidine promotes longevity in model organisms. Subsequent epidemiological and translational work in humans propelled spermidine toward dietary supplement status. De novo synthesis of polyamines tends to decrease with age, which is why their dietary sources acquire a greater importance in an aging population.

There is no documented history of spermidine being intentionally used as a traditional herbal or ethnopharmacological remedy in any specific cultural tradition. Its occurrence in traditional fermented and aged foods (cheeses, natto, soy products) means that populations consuming such diets have been exposed to higher dietary spermidine levels across history, but this was not a product of intentional therapeutic use.

4. Biosynthesis and Biochemistry

The de novo synthesis of polyamines in the organism begins with the formation of putrescine from the amino acid ornithine, catalyzed by the enzyme ornithine decarboxylase (ODC). Putrescine is converted to spermidine by spermidine synthase through the addition of a propylamine group derived from the decarboxylation of S-adenosyl-methionine. Subsequently, spermidine is transformed into spermine by spermine synthase, which adds a second propylamine group.

Polyamines are positively charged molecules present in all living organisms, where they interact with negatively charged molecules such as DNA, RNA, ATP, proteins, and phospholipids, and are involved in various cellular processes including cell growth, gene regulation, differentiation, development, and immunity.

Spermidine synchronizes an array of biological processes (such as Ca²⁺, Na⁺, K⁺-ATPase), thus maintaining membrane potential and controlling intracellular pH and volume.

Dysregulation of polyamine levels has been implicated in a variety of human pathologies, especially cancer. Additionally, decreases in the intracellular and circulating polyamine levels during aging have been reported.

5. Key Active Compounds and Mechanisms of Action

5.1 Autophagy Induction

Spermidine is a natural polyamine that stimulates cytoprotective macroautophagy/autophagy. Autophagy is the cellular process by which damaged proteins, aggregates, and organelles are sequestered and degraded by lysosomes, enabling cellular recycling and quality control.

The natural polyamine spermidine has been similarly linked to autophagy enhancement, geroprotection, and reduced incidence of cardiovascular and neurodegenerative diseases across species borders.

One of the primary molecular mechanisms by which spermidine induces autophagy involves the inhibition of the acetyltransferase EP300 (E1A binding protein p300). EP300 normally acetylates autophagy-initiating proteins such as those in the Beclin-1 complex, suppressing autophagy. Spermidine's inhibition of EP300 activity thereby relieves this suppression and promotes autophagic flux.

5.2 eIF5A Hypusination Axis

Spermidine serves as the amino-butyl group donor for the synthesis of hypusine (Nε-[4-amino-2-hydroxybutyl]-lysine) at a specific lysine residue of the eukaryotic translation initiation factor 5A (eIF5A).

Hypusination involves two enzymes: deoxyhypusine synthase (DHPS) and deoxyhypusine hydroxylase (DOHH). First, DHPS transfers the butylamine moiety of spermidine to the ε-amino group of eIF5A Lys50. This reaction is dependent upon NAD⁺ and produces deoxy-hypusinated eIF5A. Then, DOHH, an iron-dependent enzyme, hydroxylates carbon 9 of deoxy-hypusinated eIF5A Lys50, producing hypusinated eIF5A.

Aging is accompanied by a decrease of available spermidine, which is required for the hypusination of eIF5A through deoxyhypusine synthase (DHPS) and deoxyhypusine hydroxylase (DOHH). Hypusinated eIF5A is able to resolve ribosomal stalling at poly-proline tract (PPT) motifs.

Mechanistically, spermidine mediates its longevity effects via autophagy induction and hypusination of the translation regulator eIF5A. In summary, the polyamine–hypusination axis emerges as a phylogenetically conserved metabolic control hub for fasting-mediated autophagy enhancement and longevity.

5.3 Relationship to Caloric Restriction and Fasting

Spermidine levels increased upon distinct regimens of fasting or caloric restriction in yeast, flies, mice, and human volunteers. Genetic or pharmacological blockade of endogenous spermidine synthesis reduced fasting-induced autophagy in yeast, nematodes, and human cells.

Acute nutrient deprivation (fasting) causes an immediate increase in spermidine biosynthesis in yeast, flies, mice, and humans, as corroborated in four independent clinical studies. This fasting-induced surge in spermidine constitutes the critical first step of a phylogenetically conserved biochemical cascade that leads to spermidine-dependent hypusination of EIF5A, which favors the translation of the pro-macroautophagic TFEB (transcription factor EB), and hence an increase in autophagic flux.

5.4 Antioxidant and Anti-Inflammatory Properties

Spermidine, a naturally occurring polyamine in plants and animals, exhibits diverse biological functions including potential antioxidant and autophagy-modulating properties.

The polyamines spermine, spermidine, and putrescine are involved in various biological processes, notably in cell proliferation and differentiation, and also have antioxidant properties. Dietary polyamines have important implications in human health, mainly in the intestinal maturation and in the differentiation and development of the immune system. The antioxidant and anti-inflammatory effect of polyamines can also play an important role in the prevention of chronic diseases such as cardiovascular diseases.

5.5 Immune Modulation via eIF5A

Exogenously added spermidine had 100 to 1000-fold greater inhibition of the ability of dendritic cells (DCs) to interact with T cells compared with other products of arginine metabolism, which correlated with the ability of spermidine to inhibit DC activation. The inhibitory effects of spermidine on DC activation and T cell interaction were overcome by addition of GC7, demonstrating that the spermidine eIF5A-hypusine axis was responsible for immunomodulation.

5.6 Mitochondrial Function

Because age-related cardiovascular dysfunction is often accompanied by impaired mitochondrial biogenesis and function, researchers explored the ability of spermidine to attenuate cardiac aging through activation of mitochondrial biogenesis. Cardiac polyamine levels were reduced in aged (24-month-old) rats. Six-week SPD supplementation restored cardiac polyamine content, preserved myocardial ultrastructure, and inhibited mitochondrial dysfunction.

6. Scientific Evidence by Area of Use

6.1 Longevity and Aging

External supplementation of spermidine extends lifespan and health span across species, including in yeast, nematodes, flies, and mice. In humans, spermidine levels decline with aging, and a possible connection between reduced endogenous spermidine concentrations and age-related deterioration has been suggested. Recent epidemiological data support this notion, showing that an increased uptake of this polyamine with spermidine-rich food diminishes overall mortality associated with cardiovascular diseases and cancer.

In sum, spermidine is synthesized by the organism in sufficient quantities during youth, but not in old age. Thus, one may argue that, as we age, spermidine evolves to the status of a vitamin, and thus has to be supplemented from external sources to secure the maintenance of autophagic flux required for organismal homeostasis.

The natural and ubiquitously occurring polyamines (spermidine, spermine) and the diamine putrescine result from amino acid metabolism and comprise essential cellular functions, including regulation of cell growth, proliferation, and autophagy. Concentration of polyamines in the body is sustained by endogenous biosynthesis, microbial activity in the intestines, and exogenous food intake. However, it has been shown that intracellular polyamine concentrations of several organs decline with age in animals and humans.

Evidence strength: Pre-clinical (in vitro and animal) evidence for lifespan extension is consistent and robust across multiple species and independent research groups. Human evidence for longevity itself is currently observational and epidemiological, not derived from controlled trials with hard survival endpoints.

6.2 Cardiovascular Health

Supplementation of the natural polyamine spermidine effectively delays the development of experimental hypertension and the associated heart failure. Importantly, higher dietary intake of spermidine correlates with reduced blood pressure, as well as decreased overall mortality, in human cohort studies.

Recent studies highlight the benefits of polyamines for the cardiovascular system. SPD administration reduced lipid accumulation and necrotic core formation by inducing autophagy in an atherosclerosis mouse model. A large multi-center work showed that exogenous SPD administration enhanced mitophagy, promoted mitochondrial respiration, and improved diastolic function to delay cardiac aging in mice. In addition, the study revealed that high levels of dietary SPD were inversely correlated with cardiovascular disease in humans.

Spermidine, a natural polyamine, was found critically involved in cardioprotection and lifespan extension from both animal experiments and human studies. A prospective cohort study of 377 patients with acute myocardial infarction examined serum spermidine and oxidative stress markers, finding associations between spermidine levels and post-AMI prognosis. High levels of dietary spermidine intake were linked to lower blood pressure and decreased incidence and mortality of cardiovascular diseases in humans.

A study published in Nature Medicine reported that dietary supplementation with spermidine, a natural polyamine, extends lifespan and reverses aging-associated cardiac dysfunction in mice through induction of autophagy. Similar protective effects of spermidine on human cardiovascular health were also suggested by epidemiological studies.

Randomized clinical trials examining the anti-hypertensive effect of spermidine in humans are still lacking as of the time of registration of a dedicated spermidine anti-hypertension clinical trial (NCT04405388).

Evidence strength: Animal evidence for cardioprotection is strong and mechanistically well characterized. Epidemiological evidence in humans is supportive but cannot establish causation. Randomized controlled trials specifically targeting cardiovascular outcomes in humans remain ongoing or unpublished.

6.3 Cognitive Function and Neuroprotection

Age-linked fluctuations in spermidine levels may possibly contribute to the impairments in neural network and neurogenesis. Exogenously administered spermidine has been studied in brain diseases. Current studies highlight the ability of spermidine to promote longevity by inducing autophagy. However, the causal neuroprotective mechanism of spermidine in neuronal dysfunction remains unidentified.

Supplementing levels of spermidine, a body-endogenous metabolite, has been shown to promote mitochondrial respiration and delay aspects of brain aging. Mitochondrial function declines during brain aging and is suspected to play a key role in age-induced cognitive decline and neurodegeneration. Supplementing levels of spermidine has been shown to promote mitochondrial respiration and delay aspects of brain aging.

A series of human randomized trials have specifically addressed cognitive outcomes:

• Phase II pilot RCT (3 months): In a human cohort (participants with subjective cognitive decline, n=30, aged 60 to 80 years), a 3-month randomized, placebo-controlled, double-blind Phase II trial was conducted with supplementation of the spermidine-rich plant extract at a dosage of 1.2 mg/day. No differences were observed between spermidine and placebo-treated groups in vital signs, weight, clinical chemistry, and hematological parameters of safety, as well as in self-reported health status at the end of intervention.
• SmartAge Phase IIb RCT (12 months): This 12-month randomized, double-masked, placebo-controlled phase 2b trial (the SmartAge trial) was conducted between January 2017 and May 2020. In this randomized clinical trial that included 100 older adults, spermidine supplementation over 12 months did not result in a significant beneficial effect on mnemonic discrimination performance as compared with placebo. Longer-term spermidine supplementation with an increased daily supply of spermidine by about 10% did not modify memory and other biomarkers in a group of older adults at risk for Alzheimer disease. The investigators noted that the daily dose of 0.9 mg spermidine might not have been sufficient to achieve strong effects on memory function and biomarkers in cognitively healthy older individuals.

Among four interventional trials reviewed in a 2025 PMC analysis, three studies reported positive effects of SPD supplementation on cognitive function, including improvements in memory performance and cognitive assessments. However, one study did not observe significant improvement in cognitive outcomes following 12 months of supplementation. These inconsistencies may reflect the influence of several interacting factors, such as variations in study design, dosage and duration of supplementation, as well as variations in participants' baseline SPD levels and overall health status.

Evidence strength: Preliminary and mixed. Three of four human interventional trials reported cognitive benefit; one larger phase IIb trial did not reach significance on its primary endpoint. Evidence is insufficient to make definitive conclusions. Dose selection, baseline spermidine status, and study duration are identified confounders.

6.4 Immune Function

Polyamines are involved in the differentiation of immune cells as well as in regulation of inflammatory reactions, and they exert a suppressor effect on pulmonary immunologic and intestinal immunoallergic responses. In children, high polyamine intake during the first year has been significantly correlated to food allergy prevention.

Spermidine reversed features of immune dysfunction and significantly enhanced spike-specific IgG secretion, memory B cell recall responses, and neutralizing antibody activity, specifically in non-responders in one reported study of vaccine response.

Evidence strength: Primarily pre-clinical and mechanistic, with some emerging human immunological data. Not yet supported by large prospective controlled trials.

6.5 Metabolic and Hepatic Health

The polyamine spermidine is discussed as a caloric restriction mimetic and therapeutic option for obesity and related comorbidities.

In control diet-fed mice, spermidine decreased body and adipose tissue weights and reduced hepatic lipid content. The high-sucrose diet (HSD) induced hepatic lipid synthesis and accumulation and hypercholesterolemia. This was not affected by spermidine supplementation, but body weight and blood glucose were lower in HSD-spermidine compared to HSD alone.

Oral spermidine supplementation affects lipid metabolism in a diet-dependent manner, with significant reductions in body fat and weight under physiological nutrition and positive effects on weight and blood glucose under high sucrose intake, but no impact on dietary fat-related parameters.

Evidence strength: Primarily animal data. Human clinical evidence for metabolic benefits specifically attributed to spermidine supplementation is not yet established from RCTs.

6.6 Hair Biology

Spermidine has been tested and discovered to encourage hair shaft elongation and lengthen hair growth. This represents an emerging niche area of investigation with limited but growing clinical data, largely from small trials and in vitro work on human follicle cultures.

Evidence strength: Preliminary; based on in vitro human hair follicle data and small studies. Not supported by large-scale clinical trials as of available evidence.

6.7 Depression and Stress Response

Dysregulations in plasma and brain polyamine levels were observed in subjects with depression compared to controls across three independent cohorts. A double-blind, placebo-controlled study found that spermidine supplementation restored imbalances in polyamine metabolism and induced autophagic flux, significantly improving clinical symptoms. The findings identify the polyamine pathway as a key cellular hub modulating stress-related outcomes and suggest SPD supplementation as a promising and well-tolerated treatment approach for depressive disorders that is low in side effects and cost-effective.

Evidence strength: Early-stage; this area requires replication in larger trials before conclusions can be drawn.

7. Body Systems Associated with Spermidine Activity

• Cardiovascular system: Blood pressure regulation, cardiac autophagy, mitochondrial quality control in cardiomyocytes, anti-atherosclerotic effects in animal models, and epidemiological associations with reduced CVD mortality.
• Central nervous system: Memory consolidation and cognitive aging; autophagy-mediated clearance of neurotoxic aggregates; mitochondrial function in brain tissue; potential role in neuroprotection.
• Immune system: Modulation of dendritic cell activation via eIF5A hypusination; regulation of B and T cell function; intestinal immune maturation especially in early life.
• Metabolic system: Caloric restriction mimicry; hepatic lipid metabolism; blood glucose regulation under specific dietary conditions.
• Musculoskeletal system: Using targeted metabolomics, researchers found that spermidine acts as a regulatory metabolite to promote satellite cell (SC) activation and muscle regeneration in mice. Mechanistically, spermidine activates SCs via generating hypusinated eIF5A.
• Integumentary system (hair): Hair follicle elongation and growth phase extension.

8. Dosage Forms and Doses Reported in Studies

The following doses are reported strictly as stated in the cited research sources:

• 1.2 mg/day (spermidine-rich wheat germ extract): In a 3-month randomized, placebo-controlled, double-blind Phase II trial in participants with subjective cognitive decline (n=30, aged 60–80), supplementation was at a dosage of 1.2 mg/day.
• 0.9 mg/day (wheat germ extract): The daily dose of 0.9 mg spermidine used in the SmartAge 12-month trial corresponded to about 10% of the average spermidine intake per day in developed countries. The decision to use a lower-range dosage was based on previous reports of higher polyamine levels in some malignant neoplasms and a positive regulatory effect of polyamines on cell growth.
• 40 mg/day (high-purity spermidine trihydrochloride): This first safety study of a novel high-purity spermidine (hpSPD) in humans found that intake of hpSPD at 40 mg/day for up to 28 days by healthy older men resulted in no significant adverse effects compared to placebo, supporting its safety in humans.

No official or regulatory recommended daily intake (RDI) or tolerable upper intake level for spermidine supplementation has been established by any national or international health authority. Although there are no recommendations for polyamine daily intake, it is known that in stages of rapid cell growth (i.e., in the neonatal period), polyamine requirements are high.

9. Safety Considerations

9.1 General Tolerability

Findings suggest that high-purity spermidine (hpSPD) at 40 mg/day for up to 28 days is safe and well-tolerated in healthy older men. A wide safety margin in preclinical toxicology studies supports dosing at 40 mg/day.

No differences were observed between spermidine and placebo-treated groups in vital signs, weight, clinical chemistry, and hematological parameters of safety, as well as in self-reported health status at the end of intervention. The absence of any significant treatment effects in creatinine and estimated glomerular filtration rate (eGFR) plasma levels, typical biomarkers of kidney function, indicated renal health in the human cohort during spermidine supplementation.

In a preclinical toxicity study, supplementation of spermidine using a wheat germ extract did not result in morbidities or changes in behavior in BALBc/Rj mice during a 28-day repeated-dose tolerance study. Post-mortem examination of the mice organs showed no increase in tumorigenic and fibrotic events.

9.2 Dose-Related Cautions Noted in Research

The decision to use a lower-range dosage in the SmartAge trial was based on previous reports of higher polyamine levels in some malignant neoplasms and a positive regulatory effect of polyamines on cell growth. This represents a theoretical concern from the broader polyamine biology literature, wherein elevated polyamine levels have been observed in cancer tissue, though a causative relationship with oral supplementation at dietary doses has not been established in humans.

Dysregulation of polyamine levels has been implicated in a variety of human pathologies, especially cancer. This context informs ongoing caution around very high-dose supplementation in cancer-prone populations.

9.3 Circulating Polyamine Homeostasis

Surprisingly little effect on circulating polyamine homeostasis was observed when dosing at 40 mg/day. Methodological assay limits hinder detecting possible subtle changes in polyamines. Serum and urine polyamine levels changed minimally, suggesting effective homeostatic control. This suggests the body tightly regulates circulating spermidine, and oral supplementation at tested doses does not simply raise blood levels proportionally.

9.4 Interaction with Fasting and Lifestyle

Recent work shows that fasting and caloric restriction raise spermidine levels and that the polyamine pathway may be essential for fasting-mediated benefits, suggesting interaction with lifestyle factors. Answering these questions requires larger randomized controlled trials and careful long-term safety monitoring.

9.5 Populations Requiring Additional Consideration

As derived from peer-reviewed and clinical literature:

• Pregnancy and lactation: Safety data in pregnant or lactating individuals are absent from the current evidence base. No RCT has been conducted in these populations.
• Individuals with active malignancies or a history of polyamine-sensitive tumors: Theoretical concern arising from the established role of polyamines in cell proliferation; no clinical evidence of increased cancer risk from dietary-level supplementation has been documented.
• Individuals taking immunosuppressant drugs: The eIF5A-dependent immune modulatory activity of spermidine could theoretically interact with mechanisms of immunosuppression, though this interaction has not been characterized in clinical pharmacology studies.

10. Current State of Evidence and Research Gaps

Spermidine is a naturally occurring polyamine that elicits geroprotection and autophagy induction across species. A major review in Nature Aging delineates its molecular targets, effects on the hallmarks of aging, and recent insights from epidemiological and clinical studies.

In humans, emerging data suggest potential benefits for cognitive aging, cardiovascular function, and immune health, though large-scale clinical trial evidence is still developing.

Key research gaps include:

• The optimal dose and formulation for specific indications (cognition, cardiovascular health, longevity) in humans.
• Long-term (multi-year) safety data in humans across diverse populations.
• Hard clinical endpoints (e.g., incident cardiovascular events, dementia onset, all-cause mortality) from prospective RCTs, rather than biomarker-based or surrogate outcomes.
• The pharmacokinetics of oral spermidine absorption, distribution, and bioavailability in aging humans.
• Further investigation is warranted to elucidate these factors and optimize supplementation protocols for cognitive health.

References

• Wiktionary — Definition of Triamine (organic chemistry)
• Madeo F et al. — Spermidine: a physiological autophagy inducer acting as an anti-aging vitamin in humans? Autophagy, PMC6287690 (2018)
• Muñoz-Esparza NC et al. — Polyamines in Food. Frontiers in Nutrition, PMC6637774 (2019)
• Nishibori N et al. — Polyamines in foods: development of a food database. European Journal of Clinical Nutrition, PMC3022763 (2011)
• Wirth M et al. — Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. Aging, PMC5807086 (2018)
• Wirth M et al. — Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Network Open, PMC9136623 (2022)
• Wirth M et al. — SmartAge trial protocol. Alzheimer's Research & Therapy, PMC6492385 (2019)
• Schwarz C et al. — The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial. Cortex, PubMed 30388439 (2018)
• Dolan E et al. — Supplementation of spermidine at 40 mg/day has minimal effects on circulating polyamines: An exploratory double-blind randomized controlled trial in older men. Journal of Nutritional Biochemistry (2024)
• Hofer SJ et al. — Spermidine is essential for fasting-mediated autophagy and longevity. Nature Cell Biology, PMC11392816 (2024)
• Madeo F et al. — Mechanisms of spermidine-induced autophagy and geroprotection. Nature Aging (2022)
• Abdellatif M and Sedej S — Spermidine Promotes Cardioprotective Autophagy. Circulation Research (2017)
• Zhang H et al. — Spermidine alleviates cardiac aging by improving mitochondrial biogenesis and function. Aging, PMC6977682 (2020)
• Ramos-Molina B et al. — Effect of Serum Spermidine on the Prognosis in Patients with Acute Myocardial Infarction: A Cohort Study. Frontiers in Cardiovascular Medicine, PMC9002946 (2022)
• Hagemann CA et al. — Oral Supplementation with the Polyamine Spermidine Affects Hepatic but Not Pulmonary Lipid Metabolism in Lean but Not Obese Mice. Nutrients, PMC9611404 (2022)
• Madeo F et al. — Spermidine, an autophagy inducer, as a therapeutic strategy in neurological disorders. Neuropathology and Applied Neurobiology, PubMed 32873420 (2021)
• Schroeder S et al. — eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction. Cell Reports (2021)
• Schuller AP et al. — Spermidine supplementation in rare translation-associated disorders. Frontiers in Genetics, PMC7921850 (2021)
• Duncan CJA et al. — Spermidine suppresses DC activation via eIF5A hypusination and metabolic adaptation. Discovery Immunology (2025)
• Zhang Y et al. — Spermidine-eIF5A axis is essential for muscle stem cell activation via translational control. Cell Discovery (2024)
• Madeo F et al. — Dietary and Gut Microbiota Polyamines in Obesity- and Age-Related Diseases. Cell Metabolism, PMC6426781 (2019)
• He Z et al. — Spermidine for cognitive ageing: insights into observational and interventional studies. Age and Ageing, PMC12519323 (2025)
• ClinicalTrials.gov — Spermidine Anti-Hypertension Study Protocol (NCT04405388)
• Kaufmann FN et al. — Spermidine alleviates depression via control of the stress response. bioRxiv preprint (2024)
• Sulu C et al. — A Cross-Sectional Study: Nutritional Polyamines in Frequently Consumed Foods of the Turkish Population. International Journal of Food Properties, PMC5302244 (2017)
• Wikipedia — Spermidine